Retinal Vein Occlusion Treatment Global Market Report 2024

Description

Retinal vein occlusion (RVO) treatment encompasses various approaches aimed at managing complications from blocked retinal blood vessels, focusing on reducing edema and preventing further vision loss.

The primary conditions treated for retinal vein occlusion are central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). CRVO involves a blockage of the central retinal vein, which can lead to vision impairment due to disrupted blood flow and potential retinal damage. Diagnosis often includes optical coherence tomography, fundoscopic examination, and fluorescein angiography. Treatments may involve anti-vascular endothelial growth factor (Anti-VEGF) agents, corticosteroids, and other options. These treatments are used by hospitals, clinics, research institutions, academic facilities, and similar entities.

The retinal vein occlusion treatment market research report is one of a series of new reports from The Business Research Company that provides retinal vein occlusion treatment market statistics, including retinal vein occlusion treatment industry global market size, regional shares, competitors with a retinal vein occlusion treatment market share, detailed retinal vein occlusion treatment market segments, market trends and opportunities, and any further data you may need to thrive in the retinal vein occlusion treatment industry. This retinal vein occlusion treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The retinal vein occlusion treatment market size has grown strongly in recent years. It will grow from $2.11 billion in 2023 to $2.26 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to several factors, the adoption of combination therapies addressing various aspects of disease pathophysiology, the increasing prevalence of diabetes and hypertension, expanded access to healthcare services and specialized retinal care, clinical trials showing the effectiveness of new treatment options, and advancements in anti-VEGF therapies.

The retinal vein occlusion treatment market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth during the forecast period can be attributed to factors such as cost-effectiveness and favorable reimbursement policies, patient preference for non-invasive treatments, increased global healthcare spending, a growing aging population, and the development of new drugs and therapies. Key trends expected during this period include advancements in gene therapy, the use of nanotechnology for drug delivery, the application of artificial intelligence (AI) in diagnostics, the rise of telemedicine and remote monitoring, and the development of patient-centric technologies.

The growth of the retinal vein occlusion treatment market is anticipated to increase due to the rising prevalence of eye conditions. Eye conditions encompass a range of disorders affecting vision, from minor irritations and infections to serious issues such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Factors contributing to the rise in eye conditions include an aging population and the growing rates of diabetes and hypertension. Retinal vein occlusion treatment focuses on restoring blood flow and reducing inflammation to prevent vision loss and manage related complications. For example, the Centers for Disease Control and Prevention reported in January 2024 that over 3.4 million Americans aged 40 and older were blind or visually impaired, with this number expected to double by 2030. This increase in eye conditions is driving growth in the retinal vein occlusion treatment market.

Key players in the retinal vein occlusion treatment market are developing innovative products such as interchangeable biosimilars to expand treatment options and improve patient access. An interchangeable biosimilar is a biologic drug closely similar to an existing reference biologic, used as an alternative for managing inflammation and fluid leakage. For instance, in May 2024, Biocon Biologics Limited, based in India, received approval from the US Food and Drug Administration for Yesafili (aflibercept-jbvf), an interchangeable biosimilar of EYLEA (aflibercept). This drug serves as a vascular endothelial growth factor (VEGF) inhibitor and is used to treat various ophthalmic conditions, including neovascular age-related macular degeneration (wet AMD), macular edema secondary to retinal vein occlusion (branch RVO or central RVO), diabetic macular edema (DME), and myopic choroidal neovascularization (myopic CNV).

In April 2022, Samsung Biologics Co. Ltd., a South Korea-based biotechnology company, acquired Samsung Bioepis for $2.3 billion. This acquisition is expected to boost Samsung Bioepis' sales, operating margins, and capabilities in biosimilar and novel drug development. Samsung Bioepis Co. Ltd. is a South Korean biopharmaceutical company that offers treatment for retinal vein occlusion with its biosimilar product BYOOVIZ (ranibizumab-nuna).

Major companies operating in the retinal vein occlusion treatment market are Roche Holding AG, Bayer AG, Novartis International AG, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Chengdu Kanghong Pharmaceutical Group Co. Ltd., Spark Therapeutics Inc., Genentech Inc., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Aerpio Pharmaceuticals Inc., REGENXBIO Inc., Stealth BioTherapeutics Corp., Adverum Biotechnologies Inc., Graybug Vision Inc., Oxurion NV, PanOptica Inc., Clearside Biomedical Inc.

North America was the largest region in the retinal vein occlusion treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal vein occlusion treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the retinal vein occlusion treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The retinal vein occlusion treatment market consists of revenues earned by entities by providing services such as laser therapy, medication administration, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The retinal vein occlusion treatment market also includes sales of vitrectomy equipment, and optical coherence tomography (OCT) devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Retinal Vein Occlusion Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on retinal vein occlusion treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for retinal vein occlusion treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The retinal vein occlusion treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Disease Type: Central Retinal Vein Occlusion (CRVO); Branch Retinal Vein Occlusion (BRVO)
2) By Diagnosis: Optical Coherence Tomography; Fundoscopic Examination; Fluorescein Angiography
3) By Treatment: Anti-Vascular Endothelial Growth Factor (Anti-VEGF); Corticosteroid Drugs; Other Treatments
4) By End-user: Hospital And Clinics; Research And Academics; Other End-Users
Companies Mentioned: Roche Holding AG; Bayer AG; Novartis International AG; Regeneron Pharmaceuticals Inc.; Bausch Health Companies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r19767

1. Executive Summary

2. Retinal Vein Occlusion Treatment Market Characteristics

3. Retinal Vein Occlusion Treatment Market Trends And Strategies

4. Retinal Vein Occlusion Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Retinal Vein Occlusion Treatment Market Size and Growth

5.1. Global Retinal Vein Occlusion Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Retinal Vein Occlusion Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Retinal Vein Occlusion Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Retinal Vein Occlusion Treatment Market Segmentation

6.1. Global Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Central Retinal Vein Occlusion (CRVO)
Branch Retinal Vein Occlusion (BRVO)
6.2. Global Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Optical Coherence Tomography
Fundoscopic Examination
Fluorescein Angiography
6.3. Global Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Anti-Vascular Endothelial Growth Factor (Anti-VEGF)
Corticosteroid Drugs
Other Treatments
6.4. Global Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital And Clinics
Research And Academics
Other End-Users

7. Retinal Vein Occlusion Treatment Market Regional And Country Analysis

7.1. Global Retinal Vein Occlusion Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Retinal Vein Occlusion Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Retinal Vein Occlusion Treatment Market

8.1. Asia-Pacific Retinal Vein Occlusion Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Retinal Vein Occlusion Treatment Market

9.1. China Retinal Vein Occlusion Treatment Market Overview
9.2. China Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Retinal Vein Occlusion Treatment Market

10.1. India Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Retinal Vein Occlusion Treatment Market

11.1. Japan Retinal Vein Occlusion Treatment Market Overview
11.2. Japan Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Retinal Vein Occlusion Treatment Market

12.1. Australia Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Retinal Vein Occlusion Treatment Market

13.1. Indonesia Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Retinal Vein Occlusion Treatment Market

14.1. South Korea Retinal Vein Occlusion Treatment Market Overview
14.2. South Korea Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Retinal Vein Occlusion Treatment Market

15.1. Western Europe Retinal Vein Occlusion Treatment Market Overview
15.2. Western Europe Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Retinal Vein Occlusion Treatment Market

16.1. UK Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Retinal Vein Occlusion Treatment Market

17.1. Germany Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Retinal Vein Occlusion Treatment Market

18.1. France Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Retinal Vein Occlusion Treatment Market

19.1. Italy Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Retinal Vein Occlusion Treatment Market

20.1. Spain Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Retinal Vein Occlusion Treatment Market

21.1. Eastern Europe Retinal Vein Occlusion Treatment Market Overview
21.2. Eastern Europe Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Retinal Vein Occlusion Treatment Market

22.1. Russia Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Retinal Vein Occlusion Treatment Market

23.1. North America Retinal Vein Occlusion Treatment Market Overview
23.2. North America Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Retinal Vein Occlusion Treatment Market

24.1. USA Retinal Vein Occlusion Treatment Market Overview
24.2. USA Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Retinal Vein Occlusion Treatment Market

25.1. Canada Retinal Vein Occlusion Treatment Market Overview
25.2. Canada Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Retinal Vein Occlusion Treatment Market

26.1. South America Retinal Vein Occlusion Treatment Market Overview
26.2. South America Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Retinal Vein Occlusion Treatment Market

27.1. Brazil Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Retinal Vein Occlusion Treatment Market

28.1. Middle East Retinal Vein Occlusion Treatment Market Overview
28.2. Middle East Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Retinal Vein Occlusion Treatment Market

29.1. Africa Retinal Vein Occlusion Treatment Market Overview
29.2. Africa Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Retinal Vein Occlusion Treatment Market Competitive Landscape And Company Profiles

30.1. Retinal Vein Occlusion Treatment Market Competitive Landscape
30.2. Retinal Vein Occlusion Treatment Market Company Profiles
- 30.2.1. Roche Holding AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Bayer AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Novartis International AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Regeneron Pharmaceuticals Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bausch Health Companies Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Retinal Vein Occlusion Treatment Market Other Major And Innovative Companies

31.1. Santen Pharmaceutical Co. Ltd.
31.2. Chengdu Kanghong Pharmaceutical Group Co. Ltd.
31.3. Spark Therapeutics Inc.
31.4. Genentech Inc.
31.5. Apellis Pharmaceuticals Inc.
31.6. Alimera Sciences Inc.
31.7. Ocular Therapeutix Inc.
31.8. EyePoint Pharmaceuticals Inc.
31.9. Aerpio Pharmaceuticals Inc.
31.10. REGENXBIO Inc.
31.11. Stealth BioTherapeutics Corp.
31.12. Adverum Biotechnologies Inc.
31.13. Graybug Vision Inc.
31.14. Oxurion NV
31.15. PanOptica Inc.

32. Global Retinal Vein Occlusion Treatment Market Competitive Benchmarking

33. Global Retinal Vein Occlusion Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Retinal Vein Occlusion Treatment Market

35. Retinal Vein Occlusion Treatment Market Future Outlook and Potential Analysis

35.1 Retinal Vein Occlusion Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Retinal Vein Occlusion Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Retinal Vein Occlusion Treatment Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer